45 Biggest Movers From Yesterday



  • Marin Software Incorporated MRIN shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
  • Miromatrix Medical Inc. MIRO shares climbed 69.3% to settle at $15.24 after the company reported pricing of upsized initial public offering.
  • Digital Brands Group, Inc. DBGI shares gained 31.1% to close at $5.36 after the company reported channel expansion into Amazon Marketplace.
  • Confluent, Inc CFLT gained 25.1% to close at $45.02 after the company priced its IPO at $36 per share.
  • FreightCar America, Inc. RAIL gained 24.6% to settle at $7.20 amid President Joe Biden declaring that the White House had struck an infrastructure deal with a bipartisan group of senators.
  • Pieris Pharmaceuticals, Inc. PIRS climbed 23.5% to close at $4.37 after the company announced it received Orphan Drug Designation for cinrebafusp alfa for the treatment of gastric cancer.
  • Celcuity Inc. CELC gained 20.8% to settle at $30.49 on below-average volume.
  • GTT Communications, Inc. GTT jumped 20.2% to close at $2.98 after surging over 13% on Wednesday.
  • Synchronoss Technologies, Inc. SNCR climbed 19.8% to close at $2.91.
  • X Financial XYF climbed 19.7% to close at $11.56.
  • DHI Group, Inc. DHX shares jumped 19.7% to close at $3.34 after the company announced it will add $12 million to its stock buyback, increasing the overall buyback to $20 million.
  • Altisource Portfolio Solutions S.A. ASPS gained 19.7% to settle at $7.77.
  • Gold Royalty Corp. GROY rose 17.8% to close at $6.66.
  • Condor Hospitality Trust, Inc. CDOR gained 17.6% to close at $6.27.
  • Processa Pharmaceuticals, Inc. PCSA rose 16.1% to settle at $8.74. Processa Pharmaceuticals recently entered into a licensing agreement with Ocuphire Pharma to in-license RX-3117.
  • The Trade Desk, Inc. TTD jumped 16% to settle at $75.88 mid strength in advertising technology stocks after Google announced it is delaying the phase-out of third-party cookies on Chrome until 2023.
  • Regional Health Properties, Inc. RHE gained 15.6% to close at $14.48.
  • Live Ventures Incorporated LIVE jumped 15.6% to settle at $69.78.
  • SEMrush Holdings, Inc. SEMR surged 15.5% to close at $23.34.
  • Arcus Biosciences, Inc. RCUS shares surged 15.5% to close at $27.02 after the company disclosed data from the first interim analysis of the three-arm randomized Phase 2 ARC-7 study.
  • Moxian, Inc. MOXC rose 14.7% to close at $23.04 after jumping 22% on Wednesday.
  • Kaleido Biosciences, Inc. KLDO climbed 13.5% to close at $7.93 on above-average volume.
  • Grove, Inc. GRVI rose 12% to settle at $5.60 after the company priced its IPO at $5 per share.
  • Sprinklr, Inc. CXM shares gained 11.6% to close at $19.64. Sprinklr shares gained 10% on Wednesday after the company priced its IPO at $16 per share.
  • Sierra Wireless, Inc. SWIR gained 11.6% to settle at $18.63. Craig-Hallum initiated coverage on Sierra Wireless with a Buy rating and announced a price target of $22.
  • India Globalization Capital, Inc. IGC gained 11.5% to close at $1.65. IGC said it has completed the final Cohort of its Phase 1 Clinical trial on Alzheimer’s patients.
  • Uxin Limited UXIN gained 9.9% to settle at $4.11 after gaining over 7% on Wednesday.
  • Orphazyme A/S ORPH rose 9.5% to close at $8.15. Orphazyme, which recently faced a regulatory setback, said the Goldman Sachs Group briefly increased its stake in Orphazyme above 5%.
  • Lightning eMotors, Inc. ZEV gained 9.2% to close at $8.33. Oppenheimer initiated coverage on Lightning eMotors with an Outperform rating and announced a price target of $15.
  • Compugen Ltd. CGEN rose 8.9% to close at $8.47. The company recently announced updated data from its Phase 1 dose-escalation and expansion study of COM701 as a monotherapy and in a dose-escalation combination study with Bristol-Myers Squibb’s Opdivo (nivolumab).
  • Eli Lilly and Company LLY climbed 7.3% to close at $232.97 after the company said its Donanemab received U.S. FDA's Breakthrough Therapy designation for the treatment of Alzheimer's disease.
  • Tower Semiconductor Ltd. TSEM gained 6.2% to close at $29.05 after the company, and STMicroelectronics, announced an agreement by which ST will welcome Tower to its Agrate R3 300mm fab under construction on its Agrate Brianza site in Italy.
  • Aravive, Inc. ARAV rose 5.3% to close at $5.60 after the company announced initial results from the Phase 1b portion of its Phase 1b/2 study of AVB-500. The company said AVB-500 was well tolerated and they plan to expand dosing to 3 additional patients.

Check out these big penny stock gainers and losers


  • Portage Biotech Inc. PRTG shares dipped 25.4% to close at $25.95 on Thursday after the company reported pricing of public offering of 1 million ordinary shares at $23 per share.
  • Rite Aid Corporation RAD fell 14.5% to close at $17.46 after the company reported weaker-than-expected Q1 sales.
  • Adial Pharmaceuticals, Inc. ADIL shares declined 14.3% to close at $2.52 after dropping 6% on Wednesday. The company recently announced plans to enter genetic testing market following allowance of U.S. patent for genetic diagnostic test.
  • Aesthetic Medical International Holdings Group Limited AIH dipped 12.9% to settle at $7.91 after the company reported Q1 earnings results.
  • Talaris Therapeutics, Inc. TALS fell 10.9% to settle at $13.69. The company recently reported a wider quarterly loss.
  • Vinco Ventures, Inc. BBIG fell 10.7% to close at $4.26 after the company announced it will spin out its Emmersive Entertainment unit.
  • 4D Molecular Therapeutics, Inc. FDMT fell 10.4% to close at $22.20. 4D Molecular Therapeutics an update on their rare disease ophthalmology product candidate portfolio, including initial clinical safety and tolerability data for 4D-110 for choroideremia and 4D-125 for XLRP, and termination of Roche collaboration and license agreement.
  • Clearside Biomedical, Inc. CLSD tumbled 10% to settle at $4.84.
  • DouYu International Holdings Limited DOYU dropped 9.8% to close at $7.11.
  • Oasis Midstream Partners LP OMP fell 9.3% to close at $27.93. Oasis Midstream Partners priced its public offering of 3.623 million common units after the closing bell on Thursday.
  • Terns Pharmaceuticals, Inc. TERN dipped 9.2% to settle at $13.39. Terns reported initiation of patient dosing in AVIATION Phase 1b NASH clinical trial of VAP-1 Inhibitor TERN-201 after the closing bell.
  • Talos Energy Inc. TALO shares fell 6.4% to close at $17.45 after the company reported the pricing of secondary public offering of common stock.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasInformation TechnologyInternet Software & ServicesMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!